"ORDER S.O. 1665(E)- In exercise of the powers, conferred by sub- paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4 th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1064(E), dated 11 th July, 2006, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column
(6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns
(3) and (4) thereof:
Table
Equival
ent
Sl. Name of the Formulation Strength Pack Ceiling MRP*(i No Size Price nclusive (Rs.) of all taxes)
(Rs.)
(1) (2) (3) (4) (5) (6)
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
21
Each coated tab contains
1 Multivitamins Vitamin A Acetate-5000iu 10's 7.32 8.44 and Mineral Vitamin D3 -400 iu Strip/
Tablets Vitamin E -15iu / mg, Blister
Thiamine Mononitrate-10mg
Riboflavine-10mg, Pyridoxine
HCl-2mg
Cyanocobalamine-7.5mcg,
Niacinamide-50mg
Calcium Panthothenate-10mg,
Ascorbic Acid-75mg
Heavy Magnesium Oxide-30mg,
Maganese Sulphate
Monohydrate-2.8mg
Copper Sulphate-2.0mg,
Zinc Sulphate Monohydrate-
63mg
Selenium Di-oxide-70mcg
Each hard/soft gelatin capsules
contains
2 Multivitamins Vitamin A Acetate-5000iu 10's 8.80 10.15 and Mineral Vitamin B1 Strip/
Capsules Mononitrate-10mg Blister
Vitamin B2 (Riboflavine) -10mg,
Vitamin B6 (Pyriboxine HCl) -
2mg,
Vitamin B12 (Cyanocobalamine)
-7.5mcg,
Vitamin C-75mg, Vitamin D3 -
400iu
Vitamin E Acetate-15 i.u / mg
Calcium Pantothenate-10mg,
Folic Acid-1mg, Niacinamide-
50mg,
Biotin D-150mcg, Zinc Sulphate
monohydrate - 63mg
Potassium Iodide eq. to Iodine-
150mcg,
Magnesium Oxide heavy -30mg,
Copper Sulphate - 2mg,
Chromium picolinate eq. to
Chromium-25mcg
Selenium Dioxide Monohydrate
eq. to Selenium-70mcg
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
22
Sodium Molybdate Dihyderate eq. to Molybdenum-25mcg Colloidal Silicon Dioxide eq. to Silicon-1mg
Sodium Borate eq. to Boron- 150mcg
Magnase Sulphate - 2.8mg *Subject to actual payment of Government levies/taxes, as applicable. Note :
I. For all the other Vitamin formulations having composition within the prescribed range in Schedule-V under Drugs and Cosmetics Act, 1940. The Following adjustment shall be made by a manufacturer to work out the ceiling price (column no.5) for a product under the said order for formulation(s) in column No.2, when there is a change in the composition and the following factors (which are inclusive of admissible MAPE) shall be added/subtracted as the case may be to the notified ceiling price given in column No.5 of the table on the following basis.
II. to V. x x x
VI. For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
VII. The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority."
25. According to the respondents, inclusion of vitamin C and vitamin E in the impugned notification dated 27.09.2007 is sufficient for the respondent No.2-NPPA insisting that the petitioners should have sold their formulation as per the ceiling price indicated in the said notification. In this context, much emphasis is placed on paragraphs 4 and 11 of DPCO 1995 read
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
23
with Notes VI and VII appended to the impugned notification dated 27.09.2007, quoted hereinabove.
26. We have carefully considered the said contention raised on behalf of the respondents. We find that the respondents would certainly have power to fix the price of a formulation on the basis of information available with it when the manufacturer or importer of a bulk drug or formulation fails to submit an application for price fixation and also fails to furnish information as required under DPCO 1995. Such power is indeed found in paragraph 11 of DPCO 1995 read with the obligation on the manufacturer to furnish such information to the respondents under paragraph 4 thereof. The respondents are also justified in contending that the scheduled formulation indeed means a formulation containing a bulk drug specified in the first schedule to DPCO 1995, either individually or in combination with other drugs. But, even if the aforesaid contentions raised on behalf of the respondents are found to be in line with DPCO 1995, what is most crucial is that the respondent No.1 and/or respondent No.2 are required to pass an order for fixing the ceiling price of the scheduled formulation. In order to pass an order for fixing the ceiling price of the scheduled formulation under paragraph 9 of DPCO 1995, the said respondents are required to do so in accordance with the formula laid down in paragraph 7 of DPCO
1995.
27. The subject formulation in the present case is Cartigen Forte used for treatment of osteoarthritis and since its ingredients
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
24
included vitamin C and vitamin E prior to January 2010, it could be covered under the definition of Scheduled Formulation, as per paragraph 2(v) of DPCO 1995. But, respondent No.1 and/or respondent No.2 i.e. the Central Government and the NPPA were required to pass an order by notification in the official gazette under paragraph 9 of DPCO 1995 to fix the ceiling price of the subject formulation. In order to do so, the formula for calculation under paragraph 7 of DPCO 1995 was required to be applied. This is evident from clause (1) of paragraph 9 of DPCO 1995 itself, as it specifically lays down that the ceiling price would be fixed from time to time in accordance with the formula laid down in paragraph 7 thereof. A perusal of the above quoted paragraph 7 of DPCO 1995 shows that the price would have to be calculated on the basis of the following formula :
R.P.= (M.C. + C.C. + P.M. + P.C.) x (1 + MAPE/100) + ED.
28. Thus, the calculation of the ceiling price would be determined and arrived at by applying the said formula, which would necessarily entail incorporating all the relevant factors i.e. material cost, conversion cost, cost of packaging material, packaging charges, maximum allowable post manufacturing expenses (MAPE) and excise duty and that too in terms of the mechanism specifically provided in paragraph 7 of DPCO 1995. Therefore, the said respondents were required to pass an order by notification in the official gazette after calculating the ceiling price on the basis of the aforesaid formula specified in paragraph 7 of DPCO 1995. No such exercise was ever undertaken by the said
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
25
respondents in respect of the subject formulation. In such a situation, the respondents were not entitled to apply impugned notification dated 27.09.2007 to claim that the ceiling price specified therein stood applied to the subject formulation of the petitioners. A perusal of the above quoted portion of the said notification shows that the formulations for which ceiling price had been fixed were 'multivitamin and mineral tablets' and 'multivitamin and mineral capsules'. No doubt, vitamin C and vitamin E were ingredients recorded in the said formulations when ceiling price was fixed under the said notification dated 27.09.2007, but the ceiling price was arrived at after applying the formula specified in paragraph 7 of DPCO 1995. In other words, the said respondents took into consideration the aforementioned factors and then arrived at the ceiling price.
29. A perusal of Note I, VI and VII appended to the said notification dated 27.09.2007 shows the manner in which the ceiling price is to be applied, if there is a change in composition. In the said notes, there is a reference to MAPE and other such factors. Even otherwise, a perusal of the said notification dated 27.09.2007 shows that vitamin C in the formulation 'multivitamin and mineral capsules' is shown to the extent 75 mg and vitamin E in the 'multivitamin and mineral tablets' at 15 iu/mg. The said weightage of vitamin C and vitamin E, which are indeed bulk drugs included in the First Schedule to DPCO 1995, is shown in combination with other vitamins and minerals. In the subject formulation, prior to January 2010, vitamin C was only 37.5 mg
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
26
and vitamin E was only 12.5 mg. The weight of both these scheduled bulk drugs was much less than what was specified in the impugned notification dated 27.09.2007, while shown in combination with other vitamins and minerals for the formulation 'multivitamin and mineral tablets' and 'multivitamin and mineral capsules'. It is also an admitted position that from January 2010 vitamin C and vitamin E were not even ingredients in the subject formulation, thereby showing that the respondents cannot rely upon the impugned notification dated 27.09.2007 to justify their stand.
30. It is also found that the impugned notification dated 27.09.2007 specifically showing ceiling price fixed for the formulations 'multivitamin and mineral tablets' and 'multivitamin and mineral capsules' cannot be applied to the subject formulation, in which the active pharmaceutical ingredients are Glucosamine Sulfate Potassium Chloride, Chondroitin Sulfate Sodium and Methyl Sulfonyl Methane. It is also found that the ceiling price as per the aforesaid impugned notification dated 27.09.2007 is fixed for the entire formulation, the composition of which includes various vitamins and minerals, after applying the specific formula under paragraph 7 of DPCO 1995. On pointed queries put to the respondents, as to how only vitamin C from the formulation of multivitamin and mineral capsules and vitamin E from the formulation of multivitamin and mineral tablets could be segregated for ascertaining the ceiling price to then apply it to the subject formulation, there was no satisfactory response. The
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
27
reason for the same is that if the contentions raised on behalf of the respondents on the basis of the impugned notification dated 27.09.2007 are accepted and sought to be applied to the subject formulation, the specific formula contained in paragraph 7 of DPCO 1995 is rendered wholly unworkable. Even if the stand of the respondents is taken into consideration, it is an admitted position that fixing of ceiling price under paragraph 9 of DPCO 1995 for the subject formulation has not been undertaken because the specific formula under paragraph 7 thereof has not been applied for calculation and determination of the ceiling price. The aforementioned factors applied in the said formula have not been considered and determined by the respondents to undertake the exercise of calculation of ceiling price of the subject formulation and therefore, the contentions raised on behalf of the respondents in that regard are rendered wholly unsustainable.
31. There can be no doubt about the fact that reading paragraphs 4 and 11 of DPCO 1995 reserves power in the respondents to fix price of the subject formulation on the basis of the information available to them, in the absence of information being furnished by the manufacturer for fixing of price. But, the procedure prescribed under paragraph 9 read with paragraph 7 of DPCO 1995 has to be followed and a specific order by way of notification in the official gazette has to be issued in respect of the subject formulation to claim that ceiling price is applicable in a given case. No such exercise was undertaken in the context of the subject formulation of the petitioners and therefore, the very basis
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
28
of claiming that the petitioners had overcharged, is taken away. Therefore, the impugned notification dated 27.09.2007 to the extent that it is sought to be applied to the subject formulation, deserves to be set aside.
32. In the face of such a situation, the respondents seek to rely upon impugned notification dated 30.01.2009. The said notification reads as follows :
"ORDER S.O.372(E). - In exercise of the powers, conferred by paragraphs 9 and 11 of the Drugs (Prices Control) Order, 1995 read with S.O. 637(E) dated the 4th September 1997 issued by the Government of India, Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby notifies that any formulation/composition not covered in the table of standing orders issued by the NPPA that has any scheduled drug as one of its ingredients, shall be subject to the price ceiling mentioned at the respective serial number of the respective notification, as the case may be, unless the manufacturer has subsequently got a specific price fixed by the NPPA for that formulation/composition.
The manufacturer or marketing company not
complying with the ceiling prices and the condition specified in the respective notification shall be liable to deposit the overcharged amount along with interest under the provision of Drug Price Control Order, 1995 read with the Essential Commodities Act, 1995."
33. A perusal of the above quoted notification shows that it is extremely widely worded and it violates DPCO 1995 itself. Although, it has been issued purportedly by exercising power under paragraphs 9 and 11 of DPCO 1995, the crucial part of calculation of ceiling price as per formula under paragraph 7 of DPCO 1995 has been lost sight of. In fact, the impugned
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
29
notification dated 30.01.2009 has the effect of completely doing away with the formula specified in paragraph 7 of DPCO 1995. The moment the very formula for calculation of ceiling price as per paragraph 7 read with paragraph 9 is taken away, it becomes clear that the impugned notification dated 30.01.2009 is rendered ultra vires DPCO 1995 itself. We find that when ceiling price is not fixed by the respondents as per the mechanism under paragraphs 7, 9 and 11 of DPCO 1995 and it is deemed that the ceiling price is fixed when the same is ascertained as regards any of the ingredients in the formulation, the very basis of calculation and obligation upon the respondents to fix the price of scheduled formulation in terms of DPCO 1995 is taken away.
34. The impugned notification dated 30.01.2009 is clearly over broad, expansive and it operates in the teeth of the paragraphs of DPCO 1995 itself. In other words, it is beyond the power vested in respondent No.2-NPPA to issue such kind of notification. As a matter of fact, it indicates abdication of the responsibilities and obligations cast upon the Central Government and the NPPA to specifically fix ceiling price under paragraph 9 of DPCO 1995 read with the rigorous formula specified in paragraph 7 thereof. We find substance in the contentions raised on behalf of the petitioners in this regard to hold that the impugned notification dated 30.1.2009 is indeed ultra vires DPCO 1995.
35. We also find that the exercise of power by respondent No.2- NPPA purportedly under paragraphs 9 and 11 of DPCO 1995 for issuing impugned notification dated 30.01.2009, is wholly
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
30
arbitrary and hence, unsustainable. In fact, the manner in which impugned notification dated 27.09.2007 is sought to be applied to the subject formulation and the arbitrary nature of impugned notification dated 30.01.2009, show that the very basis of alleging that the petitioners overcharged in respect of the subject formulation is taken away, rendering the demand notices issued by the respondent No.2-NPPA as well as respondent No.4-Collector, as unsustainable and liable to be quashed and set aside.
36. The moment the impugned notifications dated 27.09.2007 and 30.01.2009 are found unsustainable and liable to be quashed and set aside, the impugned demand notices issued by respondents, including those issued by exercising power under MLRC, also deserve to be quashed and set aside. There is no independent basis for respondent No.4 to have exercised power under MLRC to issue demand notice for recovery of specific amounts and therefore, if the very basis of raising such demands by the respondent No.2-NPPA is found to be unsustainable, the action sought to be undertaken by respondent No.4 under MLRC is also rendered unsustainable.
37. Apart from this, there is substance in the contention raised on behalf of the petitioners that huge amount towards interest could not have been calculated on the basis of the date of basic demand notices issued by respondent No.2-NPPA, for the reason that considerable period of time was consumed due to delay on the part of respondent No.2-NPPA itself in granting hearing to the petitioners and the earlier demand notices being set aside on the
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
31
ground of violation of principles of natural justice on the part of the respondent No.2-NPPA. The time consumed in the interregnum, due to the fault of the said respondent, cannot inure to its benefit and to the detriment of the petitioners, insofar as the calculation of the interest is concerned. Thus, in terms of the law laid down by this Court in the case of Franco Indian Remedies Private Limited & Anr. vs. Union of India & Anr. (supra), at worst, the interest amount could have been calculated from the notice of demand issued after the proceedings were remanded by this Court while allowing earlier Writ Petition No. 2804 of 2015.
38. We also find substance in the contention raised on behalf of the petitioners that the impugned demand notice issued by the respondent No.4-Collector, on the basis of earlier demand notice issued by the respondent No.2-NPPA, that had been already set aside, is wholly unsustainable and deserves to be quashed on the said additional ground also.
39. But, we are of the opinion that since the impugned notifications dated 27.09.2007 and 30.01.2009 themselves are found liable to be set aside, the very basis for claiming that the petitioners had overcharged regarding the subject formulation is taken away and the writ petition deserves to be allowed on that ground alone. Therefore, there is no necessity to go into the question of violation of principles of natural justice, even after remand of the proceedings, as the subsequent demand notice simply reproduced the grounds taken in the reply affidavit filed in the earlier Writ Petition No. 2804 of 2015, and other such
Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
32
grounds. The question concerning exemption available to petitioner No.1 and its contract manufacturer, as small scale industrial unit, is also not required to be gone into, in the light of the findings rendered hereinabove, in favour of the petitioners in the context of the impugned notifications dated 27.09.2007 and
30.01.2009.
40. In view of the above, the writ petition is allowed in terms of prayer clauses (a), (b), (c), (d) and (e).
41. It is made clear that impugned notification dated 27.09.2007 is quashed to the extent of its applicability to the subject formulation of the petitioners, while impugned notification dated 30.01.2009 is quashed and set aside in its entirety.
42. As a consequence of the writ petition being allowed in terms of prayer clauses (a) to (e), the respondents shall not act upon the impugned demand notices against the petitioners.
43. Pending applications and Chamber Summons, if any, also stand disposed of.
(SHREERAM V. SHIRSAT, J.) (MANISH PITALE, J.)
Bipin Prithiani Uploaded on - 22/09/2026 Downloaded on - 23/09/2026 18:38:31
Powered by TCPDF (www.tcpdf.org)
33